Provided by Tiger Trade Technology Pte. Ltd.

INNOCARE

14.790
+0.3202.21%
Volume:14.26M
Turnover:210.01M
Market Cap:26.13B
PE:33.31
High:14.950
Open:14.430
Low:14.190
Close:14.470
52wk High:20.180
52wk Low:9.650
Shares:1.77B
HK Float Shares:1.49B
Volume Ratio:1.29
T/O Rate:0.95%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.444
ROE:12.77%
ROA:4.28%
PB:2.92
PE(LYR):33.31
PS:8.04

Loading ...

InnoCare Pharma Jumps Over 5% Intraday After Signing R&D Collaboration and License Agreement with Eli Lilly

Deep News
·
Sep 29

Movement Alert|INNOCARE Rises 5.18% in Regular Trading, Rebound Linked to Market Re-Pricing of Eli Lilly $3.35 Billion Partnership

Market Focus
·
Sep 29

UBS Keeps "Buy" Rating on InnoCare Pharma with HK$21.80 Target Price

Deep News
·
Sep 27

UBS Positive on InnoCare Pharma's Collaboration with Eli Lilly on Novel Target Programs

Stock News
·
Sep 25

Hong Kong Stocks Close Lower as Oil Shares Rise Against the Trend, While Materials, Pharma and Tech Stocks Face Pressure

Stock News
·
Sep 24

Hong Kong Stocks Slip as Investors Await Trump-Xi Trade Talks; InnoCare Pharma Falls

MT Newswires Live
·
Sep 24

Hong Kong Stock Alert | Innocare (09969) Reverses After Initial Surge, Now Down Over 10% Following $3.35 Billion Eli Lilly Collaboration

Stock News
·
Sep 24

China's InnoCare, Eli Lilly Sign Collaboration Deal Worth up to $3.35 Billion

Reuters
·
Sep 24

Innocare Pharma Forges Collaboration with Eli Lilly, Unlocking Potential Milestone Payments of Up to $3.25 Billion

Stock News
·
Sep 24

INNOCARE Enters Strategic Research and Licensing Pact with Eli Lilly for Novel Drug Development

Stock News
·
Sep 24

InnoCare Pharma - to Advance Compounds Against up to Five Targets for Unmet Medical Needs

THOMSON REUTERS
·
Sep 24

InnoCare Pharma - Eligible for up to $100 Mln Upfront and $3.25 Bln in Milestone Payments

THOMSON REUTERS
·
Sep 24

InnoCare Pharma - Eligible to Receive Single-Digit Tiered Royalties on Net Product Sales

THOMSON REUTERS
·
Sep 24

InnoCare Pharma - Enters Strategic Collaboration and License Agreement with Eli Lilly

THOMSON REUTERS
·
Sep 24

Movement Alert|INNOCARE Falls 5.02% in Regular Trading, Biotech Sector Broadly Retreats After Recent Rally

Market Focus
·
Sep 24

InnoCare Pharma Records First-Half Profit as Revenue Jumps 55.5%, Backed by Orelabrutinib Expansion

Bulletin Express
·
Sep 22

HK Movers | Innovative Drug Stocks Rally Broadly; LEPU BIO, INNOCARE, AKESO Jump Over 7%

Tiger Newspress
·
Sep 21

Movement Alert|INNOCARE Rises 5.1% in Regular Trading, First Bispecific ADC ICP-B381 Approved for Clinical Trials

Market Focus
·
Sep 21

InnoCare Issues 0.58 Million New RMB Shares Under 2024 Incentive Scheme; Hong Kong Share Count Unchanged

Bulletin Express
·
Sep 17

Hong Kong Stocks Recover as WCLC Conference Sparks Biotech Rally, While US AI Slowdown Calls Raise Questions

Stock News
·
Sep 14